Technical Analysis for MNKD - MannKind Corporation
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| A | 7.17 | 1.41% | 0.10 |
MNKD closed up 1.41 percent on Friday, November 1, 2024, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: Nov 5
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing High | Bullish | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Doji - Bearish? | Reversal | 0.00% | |
| New 52 Week High | Strength | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% |
| Alert | Time |
|---|---|
| Possible Pocket Pivot | about 17 hours ago |
| Possible NR7 | about 18 hours ago |
| 60 Minute Opening Range Breakdown | about 20 hours ago |
| Up 3% | about 21 hours ago |
| 1.5x Volume Pace | about 21 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/05/2024
MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States. Its lead product candidate includes AFREZZA inhalation powder, an insulin that is in late-stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. The company also develops MedTone and Dreamboat inhaler devices. MannKind Corporation was founded in 1991 and is headquartered in Valencia, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Organ Systems Boat Diabetes Therapeutic Products Endocrine System Insulin Hyperglycemia Inhaler
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Organ Systems Boat Diabetes Therapeutic Products Endocrine System Insulin Hyperglycemia Inhaler
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 7.3 |
| 52 Week Low | 3.17 |
| Average Volume | 2,328,945 |
| 200-Day Moving Average | 5.04 |
| 50-Day Moving Average | 6.38 |
| 20-Day Moving Average | 6.64 |
| 10-Day Moving Average | 6.77 |
| Average True Range | 0.24 |
| RSI (14) | 72.45 |
| ADX | 28.79 |
| +DI | 31.85 |
| -DI | 13.15 |
| Chandelier Exit (Long, 3 ATRs) | 6.60 |
| Chandelier Exit (Short, 3 ATRs) | 6.94 |
| Upper Bollinger Bands | 7.11 |
| Lower Bollinger Band | 6.17 |
| Percent B (%b) | 1.07 |
| BandWidth | 14.03 |
| MACD Line | 0.19 |
| MACD Signal Line | 0.14 |
| MACD Histogram | 0.0465 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 7.47 | ||||
| Resistance 3 (R3) | 7.48 | 7.39 | 7.42 | ||
| Resistance 2 (R2) | 7.39 | 7.31 | 7.39 | 7.40 | |
| Resistance 1 (R1) | 7.28 | 7.27 | 7.34 | 7.27 | 7.39 |
| Pivot Point | 7.19 | 7.19 | 7.22 | 7.19 | 7.19 |
| Support 1 (S1) | 7.08 | 7.11 | 7.14 | 7.07 | 6.95 |
| Support 2 (S2) | 6.99 | 7.07 | 6.99 | 6.94 | |
| Support 3 (S3) | 6.88 | 6.99 | 6.92 | ||
| Support 4 (S4) | 6.87 |
